240 related articles for article (PubMed ID: 9661740)
1. Steady-state serum concentrations of carbamazepine and valproic acid in obese and lean patients with epilepsy.
Suemaru K; Kawasaki H; Yasuhara K; Yao K; Furuno K; Kawakami Y; Araki H; Gomita Y; Oka E
Acta Med Okayama; 1998 Jun; 52(3):139-42. PubMed ID: 9661740
[TBL] [Abstract][Full Text] [Related]
2. Lack of interaction of gabapentin with carbamazepine or valproate.
Radulovic LL; Wilder BJ; Leppik IE; Bockbrader HN; Chang T; Posvar EL; Sedman AJ; Uthman BM; Erdman GR
Epilepsia; 1994; 35(1):155-61. PubMed ID: 8112239
[TBL] [Abstract][Full Text] [Related]
3. [Effects of carbamazepine on plasma concentrations of valproic acid and its toxic metabolite in epileptic patients].
Chen ZJ; Wang XD; Zhou LM; Fang ZY; Wang HS; Li JL; Zhou JQ; Huang HB; Huang M
Yao Xue Xue Bao; 2014 Apr; 49(4):530-4. PubMed ID: 24974473
[TBL] [Abstract][Full Text] [Related]
4. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid.
Minkova GD; Getova DP
Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330
[TBL] [Abstract][Full Text] [Related]
5. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
Steinborn B; Galas-Zgorzalewicz B
Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
[TBL] [Abstract][Full Text] [Related]
6. [Season fluctuations of carbamazepine and valproate concentration in patients with epilepsy].
Avakian GN; Oleĭnikova OM; Lagutin IuV; Khromykh EA; Bogomazova MA; Delger AB; Avakian GG
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11):34-9. PubMed ID: 24429946
[TBL] [Abstract][Full Text] [Related]
7. Effects of discontinuation of phenytoin, carbamazepine, and valproate on concomitant antiepileptic medication.
Duncan JS; Patsalos PN; Shorvon SD
Epilepsia; 1991; 32(1):101-15. PubMed ID: 1985818
[TBL] [Abstract][Full Text] [Related]
8. [The clinical relevance of serial determinations of plasma concentrations of carbamazepine and sodium valproate].
Hernández-Fustes OJ; Marcourakis T; de Bittencourt PR
Rev Neurol; 1999 Jun 1-15; 28(11):1043-7. PubMed ID: 10390769
[TBL] [Abstract][Full Text] [Related]
9. Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study.
May TW; Rambeck B; Jürgens U
Ther Drug Monit; 1999 Apr; 21(2):175-81. PubMed ID: 10217337
[TBL] [Abstract][Full Text] [Related]
10. Correlations between UGT2B7∗2 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients.
Zhang H; Zhang W; Li Y; Yan J; Zhang J; Wang B
Brain Dev; 2018 Feb; 40(2):100-106. PubMed ID: 28958730
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents.
Steinborn B
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():9-15. PubMed ID: 16119616
[TBL] [Abstract][Full Text] [Related]
12. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
[TBL] [Abstract][Full Text] [Related]
13. The influence of polytherapy on the relationships between serum carbamazepine and its metabolites in epileptic children.
Liu H; Delgado MR
Epilepsy Res; 1994 Mar; 17(3):257-69. PubMed ID: 8013448
[TBL] [Abstract][Full Text] [Related]
14. Fasting serum insulin and lipid levels in men with epilepsy.
Pylvänen V; Knip M; Pakarinen AJ; Turkka J; Kotila M; Rättyä J; Myllylä VV; Isojärvi JI
Neurology; 2003 Feb; 60(4):571-4. PubMed ID: 12601094
[TBL] [Abstract][Full Text] [Related]
15. Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy.
Isojärvi JI; Turkka J; Pakarinen AJ; Kotila M; Rättyä J; Myllylä VV
Epilepsia; 2001 Jul; 42(7):930-4. PubMed ID: 11488894
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
Jankovic SM; Milovanovic JR
Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
[TBL] [Abstract][Full Text] [Related]
19. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration.
Stockis A; Sargentini-Maier ML; Brodie MJ
Epilepsy Res; 2016 Dec; 128():163-168. PubMed ID: 27842261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]